European shares closed higher on Wednesday amid corporate earnings news and ongoing turmoil in Gaza and Ukraine.» Read More
Keith Nichols, CFO of AkzoNobel, says the company is on track to reach its targets for 2015.
*FTSEurofirst 300 closes up 1.4 pct as Wall St gains. *Alcatel-Lucent surges 9.2 percent after results. LONDON, Feb 6- European equities bounced back in good volume on Thursday after a two-week drop, with reassuring earnings reports boosting shares despite the European Central Bank dashing hopes of some immediate extra monetary easing.
*FTSEurofirst 300 up 1.4 pct, rallying with Wall St. *Alcatel-Lucent surges 8.5 percent after results. LONDON, Feb 6- European equities bounced back on Thursday after a two-week drop, with reassuring earnings reports boosting shares despite the European Central Bank dashing hopes of some immediate extra monetary easing.
NEW YORK, Feb 6- U.S. stock index futures advanced on Thursday, ahead of a rate decision by the European Central Bank, as well as U.S. labor market data and the latest round of corporate earnings. *Twitter Inc shares tumbled 23 percent to $50.80 in premarket trade. *Green Mountain Coffee Roasters Inc surged 43.4 percent to $116 before the opening bell.
*Alcatel-Lucent surges 11.5 percent after results. LONDON, Feb 6- European equities bounced back from oversold technical levels on Thursday after a sharp two-week drop, with reassuring earnings from major companies Alcatel-Lucent and AkzoNobel boosting their shares.
LONDON, Feb 6- European equities climbed higher in cautious trading ahead of rate decisions by central banks on Thursday, with reassuring earnings results from major companies such as Alcatel-Lucent and AkzoNobel boosting their shares.
Ton Büchner, CEO of AkzoNobel, says there is "fragile stabilization" in the European economy but any "disturbance" could set the continent back.
Dutch paints and chemicals company AkzoNobel reported slightly higher-than-expected fourth-quarter earnings on Thursday and said it was on track to meet its 2015 targets.
European shares closed near five-year highs on Monday, helped by gains from Philips and SAP, as well as encouraging U.S. housing data.
Shares of Dutch paints and chemicals company Akzo Nobel rose by 7 percent on Monday morning after the group said that its performance improvement program for the year was still on track and unveiled profit figures that matched market expectations.
Keith Nichols, CFO of Akzo Nobel, talks about the company's earnings which saw net profits hit 155 million euros ($212 million) after a loss of 2.37 billion euros a year ago.
Ton Buchner, CEO of AzkoNobel, says the group is stepping up its cost reduction plans to meet an improvement program target and discusses growth in China and U.S.
European shares closed slightly lower on Friday as investors locked in profits ahead of the weekend and once again focused on the ongoing discussions surrounding the "fiscal cliff" in the U.S.
Some of the names on the move ahead of the open.
The boss of paint maker Akzo Nobel has told CNBC he is "excited to be back" after his temporary departure from the firm and has revealed the U.S. arm of the business will be sold off to focus on Europe and high growth markets.
Ton Büchner, CEO of Akzo Nobel, tells CNBC that the company is selling its US operations as it lacks critical mass in North America and would require significant additional funding to be profitable.
AMSTERDAM-- With its new CEO on an extended sick leave, Dutch chemicals conglomerate Akzo Nobel NV reported Thursdsay a 2.37 billion loss in the third quarter after taking a massive impairment charge on its home paints business.
Keith Nichols, CFO on AkzoNobel, tells CNBC, demand has been weak in Europe and it is particularly evident in the more consumer facing businesses that we have.
AMSTERDAM-- The chief executive of Akzo Nobel, the world's largest maker of paints by sales, will return to work by the end of this year, the company says.
Shares in AkzoNobel fall 4.4 percent to an 11- week low as the Dutch paints maker's Chief Executive Ton Buechner is still on medical leave, dashing analysts' hopes for a quick turnaround at the company.